Mrna Covid 19 Vaccines - Vaccines

Relevant Publications

Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.

Issue Release: 2025

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production.

Issue Release: 2025

Current Status and Future Trends in Myocarditis Related to the COVID-19 Vaccines: A Visual and Bibliometric Analysis.

Issue Release: 2025

COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks.

Issue Release: 2025

Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.

Issue Release: 2025

Characterization of lipid nanoparticles using macro mass photometry: Insights into size and mass.

Issue Release: 2025

Altered Circulating Cytokine Profile Among mRNA-Vaccinated Young Adults: A Year-Long Follow-Up Study.

Issue Release: 2025

Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond.

Issue Release: 2025

In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines.

Issue Release: 2025

Characterization of intact mRNA-based therapeutics by charge detection mass spectrometry and mass photometry.

Issue Release: 2025

Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19.

Issue Release: 2025

Spike specific IgG3 and nucleocapsid IgG response in serum serve as distinguishing immunological markers between SARS-CoV-2 infection and vaccination.

Issue Release: 2025

Functional T cell response to COVID-19 vaccination with or without natural infection with SARS-CoV-2 in adults and children.

Issue Release: 2025

A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters.

Issue Release: 2025

COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.

Issue Release: 2025

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers.

Issue Release: 2025

Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial.

Issue Release: 2025

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.

Issue Release: 2025

Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice.

Issue Release: 2025

The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis.

Issue Release: 2025

Where Can You Get the DTaP Vaccine?

Why Do Adverse Events Occur?

How Do Vaccines Help Combat Antibiotic Resistance?

How are Recombinant Vaccines Made?

How Can Technology Aid in Vaccine Management?

How Does Viral Vector Technology Work?

What Role Do Regulatory Agencies Play?

What is the HPV Vaccine?

Why are Adjuvants Important?

How Effective are Measles and Rubella Vaccines?

Mrna Covid 19 Vaccines - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics